Tissue Diagnostics Market Size, Share, Trends, Growth Outlook

The Tissue Diagnostics Market Size is estimated to be US 5.4 billion in 2024. It is poised to register 8.1% growth over the forecast period from 2024 to 2030 to reach US $ 8.6 billion in 2030.

 

Tissue Diagnostics Market Overview

Technological advancements in tissue diagnostics, including the integration of digital pathology, automation, and artificial intelligence (AI) are significantly enhancing the precision and efficiency of diagnostic procedures. Additionally, the increasing prevalence of cancer and other chronic diseases are surging the demand for tissue-based diagnostics as they play a crucial role in early detection, accurate diagnosis, and personalized treatment planning. Laboratories are increasingly adopting automated tissue diagnostic platforms and digital pathology solutions. Continued innovations in tissue diagnostic technologies, including digital pathology, next-generation sequencing, multiplex immunohistochemistry, and molecular diagnostics, are enhancing the accuracy, speed, and efficiency of tissue analysis. Tissue-based tests integrated with therapeutic development are becoming more common, particularly in oncology, to tailor treatments based on individual patient characteristics. Further, rising investments in research and development activities, coupled with a growing focus on personalized medicine and targeted therapies are spurring the adoption of tissue diagnostics.

 

Tissue Diagnostics Market Dynamics

Market Trends- Automation and digitalization revolutionize diagnostic workflows, driving efficiency and precision in the Tissue Diagnostics Market while enhancing patient care

Laboratories and diagnostic facilities are increasingly adopting automated systems and digital pathology solutions to streamline workflows and improve diagnostic efficiency.

Automation in tissue diagnostics involving the use of robotics, advanced imaging technologies, and automated slide staining systems, reducing manual labour and enhancing the accuracy and reproducibility of tests are driving the market.

Further, enhancing productivity, reducing turnaround times, and enabling more precise diagnoses, ultimately contributing to better patient care and outcomes in the healthcare sector are fueling the market.

 

Market Driver- The increasing incidence of chronic diseases, notably cancer, drives the demand for advanced tissue diagnostics within the market

The rising prevalence of cancer cases globally is heightening the demand for precise and early diagnostic tools, wherein tissue diagnostics play a pivotal role.

Continuous innovation in diagnostic technologies, encouraging the development of more sophisticated tools capable of detecting biomarkers, genetic variations, and molecular signatures within tissue samples are leading to market growth.

Further, accurate cancer identification, subtype classification, prognostic evaluation, and treatment selection are fostering the market.

 

Market Opportunity- Precision Medicine and Personalized Diagnostics fuel demand for tailored solutions in the Tissue Diagnostics Market

Shift towards personalized medicine, emphasizing tailored treatment strategies based on individual patient characteristics is significantly propelling the demand for precise tissue diagnostics.

Additionally, the evolving healthcare landscape, where clinicians increasingly prioritize therapies tailored to patients' unique biological profiles, resulting in improved therapeutic outcomes and minimized adverse effects are boosting the demand.

Further, the integration of precision medicine into clinical practice are necessitating advanced tissue-based tests that can precisely identify and characterize disease biomarkers, fostering continuous innovation and the development.

 

Market Share Analysis- Consumables will register the fastest growth

The Tissue Diagnostics Market is analyzed across Consumables and Instruments. Consumables is poised to register the fastest growth. These consumables encompass a range of products including reagents, antibodies, probes, stains, and kits utilized during tissue-based analyses. Reagents and antibodies are fundamental in immunohistochemistry (IHC) and in situ hybridization (ISH) techniques, enabling the detection and visualization of specific antigens and nucleic acid sequences within tissue samples. Specialized stains and probes are employed to highlight specific structures or molecular markers in tissues, aiding pathologists in precise diagnostic interpretations. The continuous demand for consumables stems from the necessity to perform routine histopathological examinations, cancer profiling, and molecular testing, contributing significantly to the revenue stream of the tissue diagnostics sector. The consumables market witnesses ongoing innovation, characterized by the introduction of improved and more sensitive products, catering to the evolving needs of laboratories and diagnostic facilities.

 

Market Share Analysis- Immunohistochemistry held a significant market share in 2024

The Tissue Diagnostics Market is analyzed across various technologies including Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow Management and Special Staining. Of these, Immunohistochemistry held a significant market share in 2024. This technique employs antibodies labeled with chromogens to detect and localize specific antigens, aiding pathologists and clinicians in disease diagnosis, prognosis, and treatment selection. IHC is extensively utilized in cancer diagnostics to subtype tumors, assess tumor aggressiveness, and determine potential therapeutic targets based on protein expression patterns. The versatility of IHC extends beyond oncology, finding applications in various fields such as infectious diseases, autoimmune disorders, and neuroscience. Ongoing technological advancements have further amplified the significance of IHC, with the introduction of novel antibodies, automated staining platforms, and digital imaging systems enhancing the technique's sensitivity, specificity, and reproducibility.

 

Tissue Diagnostics Market News

Roche Introduces Bench Mark ULTRA PLUS System Advancing Cancer Diagnostics for Timely, Targeted Patient Care.

Gestalt Diagnostics LLC Introduces AI-Driven Algorithm Enhancing Pathologists' Cancer Classification Capabilities.

International Agency for Research on Cancer (IARC) Unveils New Atlas for Breast Cancer Early Detection.

 

Tissue Diagnostics Market Segmentation

By Product

• Consumables
  • Antibodies
  • Kits
  • Reagents
  • Probes
• Instruments
  • Slide-staining Systems
  • Scanners
  • Tissue-processing Systems
  • Other Instruments (automated cover slippers, microtomes, embedding systems, paraffin dispensers, and slide labelers)

 

By Technology

• Immunohistochemistry
• In Situ Hybridization
• Digital Pathology & Workflow Management
• Special Staining

 

By Disease Type

• Breast Cancer
• Gastric Cancer
• Lymphoma
• Prostate Cancer
• Non-small Cell Lung Cancer
• Others

 

By End User

• Hospitals
• Research Laboratories
• Pharmaceutical Companies
• Contract Research Organizations (CROs)
• Others

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

 

Tissue Diagnostics Market Companies

• Agilent Technologies Inc (United States)
• Danaher Corporation (United States)
• PHC Holdings Corporation (Japan)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Thermo Fisher Scientific Inc (United States)

 

*List not exhaustive

Tissue Diagnostics Market Outlook 2023

1 Market Overview

1.1 Introduction to the Tissue Diagnostics Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2023 Tissue Diagnostics Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Tissue Diagnostics Market Companies with Area Served

4.2.2 Products Offerings Global Tissue Diagnostics Market

 

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 post-COVID-19 Scenario- Low Growth Case

5.1.3 Post-COVID-19 Scenario- Reference Growth Case

5.1.4 Post-COVID-19 Scenario- Low Growth Case

 

6 Global Tissue Diagnostics Market Trends

6.1 Global Tissue Diagnostics Revenue (USD Million) and CAGR (%) by Type (2018-2030)

6.2 Global Tissue Diagnostics Revenue (USD Million) and CAGR (%) by Applications (2018-2030)

6.3 Global Tissue Diagnostics Revenue (USD Million) and CAGR (%) by Regions (2018-2030)

 

7 Global Tissue Diagnostics Market Revenue (USD Million) by Type, and Applications (2018-2022)

7.1 Global Tissue Diagnostics Revenue (USD Million) by Type (2018-2022)

7.1.1 Global Tissue Diagnostics Revenue (USD Million), Market Share (%) by Type (2018-2022)

7.2 Global Tissue Diagnostics Revenue (USD Million) by Applications (2018-2022)

7.2.1 Global Tissue Diagnostics Revenue (USD Million), Market Share (%) by Applications (2018-2022)

 

8 Global Tissue Diagnostics Development Regional Status and Outlook

8.1 Global Tissue Diagnostics Revenue (USD Million) By Regions (2018-2022)

8.2 North America Tissue Diagnostics Revenue (USD Million) by Type, and Application (2018-2022)

8.2.1 North America Tissue Diagnostics Revenue (USD Million) by Country (2018-2022)

8.2.2 North America Tissue Diagnostics Revenue (USD Million) by Type (2018-2022)

8.2.3 North America Tissue Diagnostics Revenue (USD Million) by Applications (2018-2022)

8.3 Europe Tissue Diagnostics Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)

8.3.1 Europe Tissue Diagnostics Revenue (USD Million), by Country (2018-2022)

8.3.2 Europe Tissue Diagnostics Revenue (USD Million) by Type (2018-2022)

8.3.3 Europe Tissue Diagnostics Revenue (USD Million) by Applications (2018-2022)

8.4 Asia Pacific Tissue Diagnostics Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)

8.4.1 Asia Pacific Tissue Diagnostics Revenue (USD Million) by Country (2018-2022)

8.4.2 Asia Pacific Tissue Diagnostics Revenue (USD Million) by Type (2018-2022)

8.4.3 Asia Pacific Tissue Diagnostics Revenue (USD Million) by Applications (2018-2022)

8.5 South America Tissue Diagnostics Revenue (USD Million), by Type, and Applications (2018-2022)

8.5.1 South America Tissue Diagnostics Revenue (USD Million), by Country (2018-2022)

8.5.2 South America Tissue Diagnostics Revenue (USD Million) by Type (2018-2022)

8.5.3 South America Tissue Diagnostics Revenue (USD Million) by Applications (2018-2022)

8.6 Middle East and Africa Tissue Diagnostics Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)

8.6.1 Middle East and Africa Tissue Diagnostics Revenue (USD Million) by Country (2018-2022)

8.6.2 Middle East and Africa Tissue Diagnostics Revenue (USD Million) by Type (2018-2022)

8.6.3 Middle East and Africa Tissue Diagnostics Revenue (USD Million) by Applications (2018-2022)

 

9 Company Profiles

 

10 Global Tissue Diagnostics Market Revenue (USD Million), by Type, and Applications (2023-2030)

10.1 Global Tissue Diagnostics Revenue (USD Million) and Market Share (%) by Type (2023-2030)

10.1.1 Global Tissue Diagnostics Revenue (USD Million), and Market Share (%) by Type (2023-2030)

10.2 Global Tissue Diagnostics Revenue (USD Million) and Market Share (%) by Applications (2023-2030)

10.2.1 Global Tissue Diagnostics Revenue (USD Million), and Market Share (%) by Applications (2023-2030)

 

11 Global Tissue Diagnostics Development Regional Status and Outlook Forecast

11.1 Global Tissue Diagnostics Revenue (USD Million) By Regions (2023-2030)

11.2 North America Tissue Diagnostics Revenue (USD Million) by Type, and Applications (2023-2030)

11.2.1 North America Tissue Diagnostics Revenue (USD) Million by Country (2023-2030)

11.2.2 North America Tissue Diagnostics Revenue (USD Million), by Type (2023-2030)

11.2.3 North America Tissue Diagnostics Revenue (USD Million), Market Share (%) by Applications (2023-2030)

11.3 Europe Tissue Diagnostics Revenue (USD Million), by Type, and Applications (2023-2030)

11.3.1 Europe Tissue Diagnostics Revenue (USD Million), by Country (2023-2030)

11.3.2 Europe Tissue Diagnostics Revenue (USD Million), by Type (2023-2030)

11.3.3 Europe Tissue Diagnostics Revenue (USD Million), by Applications (2023-2030)

11.4 Asia Pacific Tissue Diagnostics Revenue (USD Million) by Type, and Applications (2023-2030)

11.4.1 Asia Pacific Tissue Diagnostics Revenue (USD Million), by Country (2023-2030)

11.4.2 Asia Pacific Tissue Diagnostics Revenue (USD Million), by Type (2023-2030)

11.4.3 Asia Pacific Tissue Diagnostics Revenue (USD Million), by Applications (2023-2030)

11.5 South America Tissue Diagnostics Revenue (USD Million), by Type, and Applications (2023-2030)

11.5.1 South America Tissue Diagnostics Revenue (USD Million), by Country (2023-2030)

11.5.2 South America Tissue Diagnostics Revenue (USD Million), by Type (2023-2030)

11.5.3 South America Tissue Diagnostics Revenue (USD Million), by Applications (2023-2030)

11.6 Middle East and Africa Tissue Diagnostics Revenue (USD Million), by Type, and Applications (2023-2030)

11.6.1 Middle East and Africa Tissue Diagnostics Revenue (USD Million), by Region (2023-2030)

11.6.2 Middle East and Africa Tissue Diagnostics Revenue (USD Million), by Type (2023-2030)

11.6.3 Middle East and Africa Tissue Diagnostics Revenue (USD Million), by Applications (2023-2030)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Tissue Diagnostics Market Companies with Areas Served

Table 3 Products Offerings Global Tissue Diagnostics Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Tissue Diagnostics Revenue (USD Million) And CAGR (%) By Type (2018-2030)

Table 8 Global Tissue Diagnostics Revenue (USD Million) And CAGR (%) By Applications (2018-2030)

Table 9 Global Tissue Diagnostics Revenue (USD Million) And CAGR (%) By Regions (2018-2030)

Table 10 Global Tissue Diagnostics Revenue (USD Million) By Type (2018-2022)

Table 11 Global Tissue Diagnostics Revenue Market Share (%) By Type (2018-2022)

Table 12 Global Tissue Diagnostics Revenue (USD Million) By Applications (2018-2022)

Table 13 Global Tissue Diagnostics Revenue Market Share (%) By Applications (2018-2022)

Table 14 Global Tissue Diagnostics Market Revenue (USD Million) By Regions (2018-2022)

Table 15 Global Tissue Diagnostics Market Share (%) By Regions (2018-2022)

Table 16 North America Tissue Diagnostics Revenue (USD Million) By Country (2018-2022)

Table 17 North America Tissue Diagnostics Revenue (USD Million) By Type (2018-2022)

Table 18 North America Tissue Diagnostics Revenue (USD Million) By Applications (2018-2022)

Table 19 Europe Tissue Diagnostics Revenue (USD Million) By Country (2018-2022)

Table 20 Europe Tissue Diagnostics Revenue (USD Million) By Type (2018-2022)

Table 21 Europe Tissue Diagnostics Revenue (USD Million) By Applications (2018-2022)

Table 22 Asia Pacific Tissue Diagnostics Revenue (USD Million) By Country (2018-2022)

Table 23 Asia Pacific Tissue Diagnostics Revenue (USD Million) By Type (2018-2022)

Table 24 Asia Pacific Tissue Diagnostics Revenue (USD Million) By Applications (2018-2022)

Table 25 South America Tissue Diagnostics Revenue (USD Million) By Country (2018-2022)

Table 26 South America Tissue Diagnostics Revenue (USD Million) By Type (2018-2022)

Table 27 South America Tissue Diagnostics Revenue (USD Million) By Applications (2018-2022)

Table 28 Middle East and Africa Tissue Diagnostics Revenue (USD Million) By Region (2018-2022)

Table 29 Middle East and Africa Tissue Diagnostics Revenue (USD Million) By Type (2018-2022)

Table 30 Middle East and Africa Tissue Diagnostics Revenue (USD Million) By Applications (2018-2022)

Table 31 Financial Analysis

Table 32 Global Tissue Diagnostics Revenue (USD Million) By Type (2023-2030)

Table 33 Global Tissue Diagnostics Revenue Market Share (%) By Type (2023-2030)

Table 34 Global Tissue Diagnostics Revenue (USD Million) By Applications (2023-2030)

Table 35 Global Tissue Diagnostics Revenue Market Share (%) By Applications (2023-2030)

Table 36 Global Tissue Diagnostics Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)

Table 37 North America Tissue Diagnostics Revenue (USD)By Country (2023-2030)

Table 38 North America Tissue Diagnostics Revenue (USD Million) By Type (2023-2030)

Table 39 North America Tissue Diagnostics Revenue (USD Million) By Applications (2023-2030)

Table 40 Europe Tissue Diagnostics Revenue (USD Million) By Country (2023-2030)

Table 41 Europe Tissue Diagnostics Revenue (USD Million) By Type (2023-2030)

Table 42 Europe Tissue Diagnostics Revenue (USD Million) By Applications (2023-2030)

Table 43 Asia Pacific Tissue Diagnostics Revenue (USD Million) By Country (2023-2030)

Table 44 Asia Pacific Tissue Diagnostics Revenue (USD Million) By Type (2023-2030)

Table 45 Asia Pacific Tissue Diagnostics Revenue (USD Million) By Applications (2023-2030)

Table 46 South America Tissue Diagnostics Revenue (USD Million) By Country (2023-2030)

Table 47 South America Tissue Diagnostics Revenue (USD Million) By Type (2023-2030)

Table 48 South America Tissue Diagnostics Revenue (USD Million) By Applications (2023-2030)

Table 49 Middle East and Africa Tissue Diagnostics Revenue (USD Million) By Region (2023-2030)

Table 50 Middle East and Africa Tissue Diagnostics Revenue (USD Million) By Region (2023-2030)

Table 51 Middle East and Africa Tissue Diagnostics Revenue (USD Million) By Type (2023-2030)

Table 52 Middle East and Africa Tissue Diagnostics Revenue (USD Million) By Applications (2023-2030)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Tissue Diagnostics Revenue (USD Million) By Type (2018-2022)

Figure 4 Global Tissue Diagnostics Revenue Market Share (%) By Type (2022)

Figure 5 Global Tissue Diagnostics Revenue (USD Million) By Applications (2018-2022)

Figure 6 Global Tissue Diagnostics Revenue Market Share (%) By Applications (2022)

Figure 7 Global Tissue Diagnostics Market Revenue (USD Million) By Regions (2018-2022)

Figure 8 Global Tissue Diagnostics Market Share (%) By Regions (2022)

Figure 9 North America Tissue Diagnostics Revenue (USD Million) By Country (2018-2022)

Figure 10 North America Tissue Diagnostics Revenue (USD Million) By Type (2018-2022)

Figure 11 North America Tissue Diagnostics Revenue (USD Million) By Applications (2018-2022)

Figure 12 Europe Tissue Diagnostics Revenue (USD Million) By Country (2018-2022)

Figure 13 Europe Tissue Diagnostics Revenue (USD Million) By Type (2018-2022)

Figure 14 Europe Tissue Diagnostics Revenue (USD Million) By Applications (2018-2022)

Figure 15 Asia Pacific Tissue Diagnostics Revenue (USD Million) By Country (2018-2022)

Figure 16 Asia Pacific Tissue Diagnostics Revenue (USD Million) By Type (2018-2022)

Figure 17 Asia Pacific Tissue Diagnostics Revenue (USD Million) By Applications (2018-2022)

Figure 18 South America Tissue Diagnostics Revenue (USD Million) By Country (2018-2022)

Figure 19 South America Tissue Diagnostics Revenue (USD Million) By Type (2018-2022)

Figure 20 South America Tissue Diagnostics Revenue (USD Million) By Applications (2018-2022)

Figure 21 Middle East and Africa Tissue Diagnostics Revenue (USD Million) By Region (2018-2022)

Figure 22 Middle East and Africa Tissue Diagnostics Revenue (USD Million) By Type (2018-2022)

Figure 23 Middle East and Africa Tissue Diagnostics Revenue (USD Million) By Applications (2018-2022)

Figure 24 Global Tissue Diagnostics Revenue (USD Million) By Type (2023-2030)

Figure 25 Global Tissue Diagnostics Revenue Market Share (%) By Type (2030)

Figure 26 Global Tissue Diagnostics Revenue (USD Million) By Applications (2023-2030)

Figure 27 Global Tissue Diagnostics Revenue Market Share (%) By Applications (2030)

Figure 28 Global Tissue Diagnostics Market Revenue (USD Million) By Regions (2023-2030)

Figure 29 North America Tissue Diagnostics Revenue (USD Million) By Country (2023-2030)

Figure 30 North America Tissue Diagnostics Revenue (USD Million) By Type (2023-2030)

Figure 31 North America Tissue Diagnostics Revenue (USD Million) By Applications (2023-2030)

Figure 32 Europe Tissue Diagnostics Revenue (USD Million) By Country (2023-2030)

Figure 33 Europe Tissue Diagnostics Revenue (USD Million) By Type (2023-2030)

Figure 34 Europe Tissue Diagnostics Revenue (USD Million) By Applications (2023-2030)

Figure 35 Asia Pacific Tissue Diagnostics Revenue (USD Million) By Country (2023-2030)

Figure 36 Asia Pacific Tissue Diagnostics Revenue (USD Million) By Type (2023-2030)

Figure 37 Asia Pacific Tissue Diagnostics Revenue (USD Million) By Applications (2023-2030)

Figure 38 South America Tissue Diagnostics Revenue (USD Million) By Country (2023-2030)

Figure 39 South America Tissue Diagnostics Revenue (USD Million) By Type (2023-2030)

Figure 40 South America Tissue Diagnostics Revenue (USD Million) By Applications (2023-2030)

Figure 41 Middle East and Africa Tissue Diagnostics Revenue (USD Million) By Region (2023-2030)

Figure 42 Middle East and Africa Tissue Diagnostics Revenue (USD Million) By Region (2023-2030)

Figure 43 Middle East and Africa Tissue Diagnostics Revenue (USD Million) By Type (2023-2030)

Figure 44 Middle East and Africa Tissue Diagnostics Revenue (USD Million) By Applications (2023-2030)

Figure 45 Bottom-Up and Top-Down Approaches For This Report

Figure 46 Data Triangulation

 

By Product

• Consumables
  • Antibodies
  • Kits
  • Reagents
  • Probes
• Instruments
  • Slide-staining Systems
  • Scanners
  • Tissue-processing Systems
  • Other Instruments (automated cover slippers, microtomes, embedding systems, paraffin dispensers, and slide labelers)

 

By Technology

• Immunohistochemistry
• In Situ Hybridization
• Digital Pathology & Workflow Management
• Special Staining

 

By Disease Type

• Breast Cancer
• Gastric Cancer
• Lymphoma
• Prostate Cancer
• Non-small Cell Lung Cancer
• Others

 

By End User

• Hospitals
• Research Laboratories
• Pharmaceutical Companies
• Contract Research Organizations (CROs)
• Others

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)